Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Tanner

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Neurology|March 1, 1993
Vitamin E and PDC C Tangney, C M Tanner
Annals of Internal Medicine|April 1, 1982
Pergolide mesylate: new therapy for Parkinson diseaseC M Tanner, H L Klawans
Current Opinion in Neurology|September 2, 2000
Epidemiology of Parkinson's disease and akinetic syndromesC M Tanner, D A Aston
Neurology|January 3, 2001
Selegiline and Parkinson's disease: it's déjà vu-againJ W Langston, C M Tanner
Journal of the American Podiatric Medical Association|May 22, 2001
The effect of high-Dye and low-Dye taping on rearfoot motionA M Keenan, C M Tanner
Clinical Neuropharmacology|January 1, 1986
Tardive dyskinesia: prevention and treatmentC M Tanner, H L Klawans
Advances in Neurology|January 1, 1988
Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome)H L Klawans, C M Tanner
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Gilles de la Tourette's syndrome in twins: clinical and neurochemical dataC G Goetz, C M Tanner
Current Opinion in Neurology|August 1, 1994
Epidemiology of movement disordersC M Tanner, S M Goldman
Lancet (London, England)|March 11, 2000
Parkinson's disease and motor-neuron disease in former prisoners-of-warW F Page, C M Tanner
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Neurology|March 1, 1993
Vitamin E and PDC C Tangney, C M Tanner
Annals of Internal Medicine|April 1, 1982
Pergolide mesylate: new therapy for Parkinson diseaseC M Tanner, H L Klawans
Current Opinion in Neurology|September 2, 2000
Epidemiology of Parkinson's disease and akinetic syndromesC M Tanner, D A Aston
Neurology|January 3, 2001
Selegiline and Parkinson's disease: it's déjà vu-againJ W Langston, C M Tanner
Journal of the American Podiatric Medical Association|May 22, 2001
The effect of high-Dye and low-Dye taping on rearfoot motionA M Keenan, C M Tanner
Clinical Neuropharmacology|January 1, 1986
Tardive dyskinesia: prevention and treatmentC M Tanner, H L Klawans
Advances in Neurology|January 1, 1988
Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome)H L Klawans, C M Tanner
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Gilles de la Tourette's syndrome in twins: clinical and neurochemical dataC G Goetz, C M Tanner
Current Opinion in Neurology|August 1, 1994
Epidemiology of movement disordersC M Tanner, S M Goldman
Lancet (London, England)|March 11, 2000
Parkinson's disease and motor-neuron disease in former prisoners-of-warW F Page, C M Tanner
Pageof 14